申请人:Joshi Kalpana Sanjay
公开号:US20120316216A1
公开(公告)日:2012-12-13
The present invention relates to the use of a compound of formula 1,
a stereoisomer or a tautomer thereof, or a pharmaceutically acceptable salt or a pharmaceutically acceptable solvate thereof, for the treatment of an inflammatory disorder. The invention further relates to a pharmaceutical composition comprising a compound of formula 1 and at least one pharmaceutically acceptable carrier, for use in the treatment of an inflammatory disorder. The invention also relates to a method for the treatment of an inflammatory disorder by administering a therapeutically effective amount of the compound of formula 1 to a subject in need thereof.
本发明涉及使用式1的化合物、立体异构体或其互变异构体,或其药学上可接受的盐或药学上可接受的溶剂,用于治疗炎症性疾病。本发明还涉及一种制药组合物,包括式1的化合物和至少一种药学上可接受的载体,用于治疗炎症性疾病。本发明还涉及一种治疗炎症性疾病的方法,通过向需要治疗的受体中给予式1化合物的治疗有效量来进行。